{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:55:08Z","timestamp":1791464108602,"version":"4.3.4"},"reference-count":276,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbcan.2026.189733","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:05:36Z","timestamp":1791216336000},"page":"189733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic reprogramming and plasticity in breast Cancer: Mechanisms driving tumor progression, metastasis, and therapeutic resistance"],"prefix":"10.1016","volume":"1881","author":[{"given":"Jie","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12943-026-02711-9","article-title":"Antibody-drug conjugates in breast cancer: from mechanism to revolutionizing clinical practice","volume":"25","author":"Li","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189733_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218690","article-title":"Immunotherapy resistance in triple-negative breast Cancer: mechanisms and emerging therapeutic strategies","volume":"658","author":"Zhao","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast Cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189733_bb0025","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1172\/JCI60534","article-title":"Heterogeneity in breast cancer","volume":"121","author":"Polyak","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"6797","key":"10.1016\/j.bbcan.2026.189733_bb0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"6487","key":"10.1016\/j.bbcan.2026.189733_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"5930","key":"10.1016\/j.bbcan.2026.189733_bb0050","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189733_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2026.104245","article-title":"Nitric oxide-driven Warburg reprogramming at the NOS2-COX2 axis: an integrative engine of cancer hallmarks","volume":"95","author":"Coutinho","year":"2026","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189396","article-title":"Metabolic reprogramming in breast cancer: pathways driving progression, drug resistance, and emerging therapeutics","volume":"1880","author":"Garg","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189733_bb0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189733_bb0080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"R\u00f6hrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"7360","key":"10.1016\/j.bbcan.2026.189733_bb0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189733_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103276","article-title":"Metastatic breast cancer cells are metabolically reprogrammed to maintain redox homeostasis during metastasis","volume":"75","author":"Biondini","year":"2024","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189733_bb0100","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","article-title":"Metabolic interactions in the tumor microenvironment","volume":"27","author":"Lyssiotis","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2026.189733_bb0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K\u2013AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb0120","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1158\/2159-8290.CD-19-1493","article-title":"Epigenetic switch-induced viral mimicry evasion in chemotherapy-resistant breast Cancer","volume":"10","author":"Deblois","year":"2020","journal-title":"Cancer Discov."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189733_bb0125","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1158\/0008-5472.CAN-16-0266","article-title":"Metabolic plasticity as a determinant of tumor growth and metastasis","volume":"76","author":"Lehu\u00e9d\u00e9","year":"2016","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb0130","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0135","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2019.03.005","article-title":"A single-cell atlas of the tumor and immune ecosystem of human breast Cancer","volume":"177","author":"Wagner","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0140","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s13277-013-0707-1","article-title":"Metabolic phenotypes in triple-negative breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbcan.2026.189733_bb0145","article-title":"Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbcan.2026.189733_bb0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13058-016-0712-6","article-title":"Cancer stem cell metabolism","volume":"18","author":"Peiris-Pag\u00e8s","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semradonc.2018.10.003","article-title":"Targeting cancer stem cell redox metabolism to enhance therapy responses","volume":"29","author":"Luo","year":"2019","journal-title":"Semin. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0160","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward minimal residual disease-directed therapy in melanoma","volume":"174","author":"Rambow","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbcan.2018.04.011","article-title":"The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance","volume":"1870","author":"Biancur","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"issue":"7873","key":"10.1016\/j.bbcan.2026.189733_bb0175","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","article-title":"Cycling cancer persister cells arise from lineages with distinct programs","volume":"596","author":"Oren","year":"2021","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107701","article-title":"Epigenetic reprogramming of Cancer-associated fibroblasts deregulates glucose metabolism and facilitates progression of breast Cancer","volume":"31","author":"Becker","year":"2020","journal-title":"Cell Rep."},{"issue":"66","key":"10.1016\/j.bbcan.2026.189733_bb0185","doi-asserted-by":"crossref","first-page":"110426","DOI":"10.18632\/oncotarget.22786","article-title":"Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41523-021-00324-7","article-title":"Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer","volume":"7","author":"Gyamfi","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb0195","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0200","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor Immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"7851","key":"10.1016\/j.bbcan.2026.189733_bb0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189733_bb0210","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb0215","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd3504","article-title":"Targeting cancer metabolism: a therapeutic window opens","volume":"10","author":"Vander Heiden","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13058-025-02194-4","article-title":"Metformin and its derivatives in breast cancer: from glycaemic control to tumor-intrinsic pathways","volume":"28","author":"Alim","year":"2025","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0225","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189733_bb0230","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"6392","key":"10.1016\/j.bbcan.2026.189733_bb0235","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1126\/science.aar5986","article-title":"The nutrient environment affects therapy","volume":"360","author":"Muir","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0240","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1073\/pnas.1808950116","article-title":"Spatially resolved metabolomics to discover tumor-associated metabolic alterations","volume":"116","author":"Sun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0245","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1038\/s41467-019-11738-0","article-title":"Metabolic landscape of the tumor microenvironment at single-cell resolution","volume":"10","author":"Xiao","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0250","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/0008-5472.CAN-21-2745","article-title":"Integrated metabolic profiling and transcriptional analysis reveals therapeutic modalities for targeting rapidly proliferating breast cancers","volume":"82","author":"Liao","year":"2022","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189733_bb0255","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.3390\/cancers12123869","article-title":"Breast Cancer organoids model patient-specific response to drug treatment","volume":"12","author":"Campaner","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0260","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb0270","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neo.2015.08.005","article-title":"Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment","volume":"17","author":"Simoes","year":"2015","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0275","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.medj.2021.03.009","article-title":"Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancer","volume":"2","author":"Ghergurovich","year":"2021","journal-title":"Med"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0280","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbamcr.2012.11.013","article-title":"Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids","volume":"1833","author":"Mandujano-Tinoco","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2026.189733_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1042835","article-title":"The relevance between hypoxia-dependent spatial transcriptomics and the prognosis and efficacy of immunotherapy in claudin-low breast cancer","volume":"13","author":"Sun","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0290","article-title":"Combined single-cell and spatial transcriptomics reveal the metabolic evolvement of breast Cancer during early dissemination","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0295","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","article-title":"Energy metabolism in tumor cells","volume":"274","author":"Moreno-S\u00e1nchez","year":"2007","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb0300","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s12015-025-10956-y","article-title":"Metabolic plasticity and Cancer stem cell metabolism: exploring the glycolysis-OXPHOS switch as a mechanism for resistance and tumorigenesis","volume":"21","author":"Keoh","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"issue":"3191","key":"10.1016\/j.bbcan.2026.189733_bb0305","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0310","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit Cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"63","key":"10.1016\/j.bbcan.2026.189733_bb0315","doi-asserted-by":"crossref","first-page":"106693","DOI":"10.18632\/oncotarget.21601","article-title":"Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome","volume":"8","author":"Benito","year":"2017","journal-title":"Oncotarget"},{"issue":"34","key":"10.1016\/j.bbcan.2026.189733_bb0320","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","article-title":"Glycolysis inhibition for anticancer treatment","volume":"25","author":"Pelicano","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0330","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1002\/jcp.30189","article-title":"Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment","volume":"236","author":"Tsai","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189733_bb0335","first-page":"1279","article-title":"GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression","volume":"26","author":"Pinheiro","year":"2011","journal-title":"Histol. Histopathol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0340","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12253-012-9500-5","article-title":"Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers","volume":"18","author":"Krzeslak","year":"2012","journal-title":"Pathol. Oncol. Res."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189733_bb0345","doi-asserted-by":"crossref","first-page":"13482","DOI":"10.1074\/jbc.M708216200","article-title":"Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding","volume":"283","author":"Abu-Hamad","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0350","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0355","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1002\/ptr.70337","article-title":"Apigenin inhibits triple-negative breast Cancer growth by dual targeting GPX4\/SLC7A11-mediated Ferroptosis and PKM2\/GLUT1-mediated aerobic glycolysis","volume":"40","author":"Zhu","year":"2026","journal-title":"Phytother. Res."},{"issue":"7184","key":"10.1016\/j.bbcan.2026.189733_bb0360","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0365","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"issue":"7375","key":"10.1016\/j.bbcan.2026.189733_bb0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb0375","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/neuonc\/noag114","article-title":"LDHA-mediated CREB1 Lactylation promotes breast Cancer brain metastasis by transcriptionally activating cytoskeletal remodeling","volume":"28","author":"Liu","year":"2026","journal-title":"Neuro-Oncology"},{"issue":"7519","key":"10.1016\/j.bbcan.2026.189733_bb0380","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0385","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0390","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","article-title":"Acidity generated by the tumor microenvironment drives local invasion","volume":"73","author":"Estrella","year":"2013","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0395","first-page":"1194","article-title":"Cellular pH gradient in tumor versus normal tissue","volume":"56","author":"Gerweck","year":"1996","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0400","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","article-title":"Lactate metabolism in human lung tumors","volume":"171","author":"Faubert","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0405","first-page":"119","article-title":"Reexamining cancer metabolism: lactate production for carcinogenesis","volume":"38","author":"San-Mill\u00e1n","year":"2017","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075154","article-title":"Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer","volume":"8","author":"Kennedy","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0415","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.yexcr.2011.11.014","article-title":"Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment","volume":"318","author":"Rattigan","year":"2012","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb0420","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1172\/JCI67230","article-title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations","volume":"123","author":"Semenza","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189733_bb0425","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","article-title":"Cancer\u2019s molecular sweet tooth and the Warburg effect","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189733_bb0430","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-03-2904","article-title":"Akt stimulates aerobic glycolysis in cancer cells","volume":"64","author":"Elstrom","year":"2004","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189733_bb0435","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","article-title":"MYC-induced cancer cell energy metabolism and therapeutic opportunities","volume":"15","author":"Dang","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0440","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","article-title":"PDK1-dependent metabolic reprogramming dictates metastatic potential in breast Cancer","volume":"22","author":"Dupuy","year":"2015","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189733_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/ncb3039","article-title":"PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0450","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/antiox15040459","article-title":"Therapy as a state-generator: dynamic phenotypic landscapes and adaptive stress circuits in chemotherapy resistance of breast Cancer","volume":"15","author":"Park","year":"2026","journal-title":"Antioxidants (Basel)"},{"issue":"21","key":"10.1016\/j.bbcan.2026.189733_bb0455","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-20-3242","article-title":"Oxidative phosphorylation is a metabolic vulnerability in chemotherapy-resistant triple-negative breast Cancer","volume":"81","author":"Evans","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0460","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1038\/s41467-023-40022-5","article-title":"Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers","volume":"14","author":"El-Botty","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0465","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0470","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-025-02133-x","article-title":"Precise targeting of transcriptional co-activators YAP\/TAZ annihilates chemoresistant brCSCs by alteration of their mitochondrial homeostasis","volume":"10","author":"Talukdar","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0475","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1158\/0008-5472.CAN-11-2967","article-title":"PGC-1alpha promotes the growth of ErbB2\/Neu-induced mammary tumors by regulating nutrient supply","volume":"72","author":"Klimcakova","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189733_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155945","article-title":"Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance","volume":"133","author":"Luo","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbcan.2026.189733_bb0485","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1741-7007-12-34","article-title":"Mitochondria as signaling organelles","volume":"12","author":"Chandel","year":"2014","journal-title":"BMC Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb0490","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb0495","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0500","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cmet.2017.09.006","article-title":"PGC-1alpha promotes breast Cancer metastasis and confers bioenergetic flexibility against metabolic drugs","volume":"26","author":"Andrzejewski","year":"2017","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0505","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1158\/0008-5472.CAN-15-2038","article-title":"miR-155 drives metabolic reprogramming of ER+ breast Cancer cells following Long-term estrogen deprivation and predicts clinical response to aromatase inhibitors","volume":"76","author":"Bacci","year":"2016","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb0510","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb0515","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0520","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2014mode of action and clinical implications","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189733_bb0525","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0530","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0535","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine metabolism in cancer: understanding the heterogeneity","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2026.189733_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108295","article-title":"Synergistic dual targeting of mTOR and GLS1 overcomes glutamine-driven resistance in triple-negative breast cancer","volume":"230","author":"Lyu","year":"2026","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb0545","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0550","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189733_bb0555","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/onc.2015.381","article-title":"ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer","volume":"35","author":"van Geldermalsen","year":"2016","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0560","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/onc.2009.358","article-title":"Q\u2019s next: the diverse functions of glutamine in metabolism","volume":"29","author":"DeBerardinis","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0565","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41420-025-02714-3","article-title":"Metabolic interplay between exogenous cystine and glutamine dependence in triple-negative breast cancer","volume":"11","author":"Ge","year":"2025","journal-title":"Cell Death Discov."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189733_bb0570","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrc.2016.82","article-title":"Metabolic control of epigenetics in cancer","volume":"16","author":"Kinnaird","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0575","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev-pathmechdis-111523-023424","article-title":"Integration and intersection of Cancer metabolism with epigenetic pathways in gliomas","volume":"21","author":"Natarajan","year":"2026","journal-title":"Annu. Rev. Pathol."},{"issue":"7443","key":"10.1016\/j.bbcan.2026.189733_bb0580","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0585","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1021\/acsnano.5c16112","article-title":"A dual glutathione-depleting nanoparticle loaded with porcine pancreatic elastase for neoadjuvant chemotherapy of triple negative breast Cancer","volume":"20","author":"Xia","year":"2026","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0590","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0595","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0600","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13046-026-03769-5","article-title":"Adipocyte-rich microenvironment promotes TNBC progression through SIRT6-associated ACSL5 dysregulation and lipid storage-associated phenotypes","volume":"45","author":"Li","year":"2026","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0605","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.plipres.2013.08.005","article-title":"Lipogenesis and lipolysis: pathways exploited by cancer cells","volume":"52","author":"Zaidi","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0610","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41419-026-08913-9","article-title":"IRX1 suppresses breast cancer progression by inhibiting fatty acid de novo synthesis through downregulating ACACA expression","volume":"17","author":"Liu","year":"2026","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0615","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3390\/cancers13051132","article-title":"Fatty acid synthase confers tamoxifen resistance to ER+\/HER2+ breast Cancer","volume":"13","author":"Menendez","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0620","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/s41467-023-37501-0","article-title":"DAXX drives de novo lipogenesis and contributes to tumorigenesis","volume":"14","author":"Mahmud","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189733_bb0625","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1158\/0008-5472.CAN-05-4673","article-title":"Fatty acid synthase and cancer: new application of an old pathway","volume":"66","author":"Kuhajda","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0630","first-page":"358","article-title":"Increased lipogenesis in cancer cells: new players, novel targets","volume":"9","author":"Swinnen","year":"2006","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbcan.2026.189733_bb0635","doi-asserted-by":"crossref","DOI":"10.1038\/npjbcancer.2016.28","article-title":"Palmitoylation: a protein S-acylation with implications for breast cancer","volume":"2","author":"Anderson","year":"2016","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0640","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/bcr3077","article-title":"A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines","volume":"13","author":"Puig","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0645","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13058-016-0713-5","article-title":"Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer","volume":"18","author":"Simigdala","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"6162","key":"10.1016\/j.bbcan.2026.189733_bb0650","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0655","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.celrep.2013.10.006","article-title":"27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth","volume":"5","author":"Wu","year":"2013","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0660","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13058-025-01991-1","article-title":"Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells","volume":"27","author":"Ward","year":"2025","journal-title":"Breast Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb0665","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.3390\/molecules23081941","article-title":"Lipid droplets in cancer: guardians of fat in a stressful world","volume":"23","author":"Petan","year":"2018","journal-title":"Molecules"},{"issue":"32","key":"10.1016\/j.bbcan.2026.189733_bb0670","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202502060","article-title":"Synergistic combination of tamoxifen-Tetraphenylethylene co-assembled micelles and orlistat-induced lipid droplet inhibition to overcome tamoxifen resistance","volume":"14","author":"Park","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb0675","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/pros.24680","article-title":"Cancer cells employ lipid droplets to survive toxic stress","volume":"84","author":"Kostecka","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.bbcan.2026.189733_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2026.140204","article-title":"Dual metabolic reprogramming by metal-polyphenol nanoplatform enhances ferroptotic therapy for triple-negative breast cancer","volume":"714","author":"Li","year":"2026","journal-title":"J. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0685","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/stem.1837","article-title":"Lipid droplets: a new player in colorectal cancer stem cells unveiled by spectroscopic imaging","volume":"33","author":"Tirinato","year":"2015","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0690","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ijc.32138","article-title":"LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer","volume":"145","author":"Cadenas","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189733_bb0695","article-title":"Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via beta-hydroxybutyrate","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189733_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111881","article-title":"Adipose tissue-breast Cancer crosstalk leads to increased tumor lipogenesis associated with enhanced tumor growth","volume":"22","author":"Micallef","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0705","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13058-018-1088-6","article-title":"Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP)","volume":"21","author":"Lehuede","year":"2019","journal-title":"Breast Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189733_bb0710","article-title":"YAP dictates mitochondrial redox homeostasis to facilitate obesity-associated breast Cancer progression","volume":"9","author":"Dai","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bbcan.2026.189733_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101939","article-title":"Redox profile of breast tumor and associated adipose tissue in premenopausal women - interplay between obesity and malignancy","volume":"41","author":"Kalezic","year":"2021","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0720","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1210\/jc.2016-3606","article-title":"Menopause is a determinant of breast aromatase expression and its associations with BMI, inflammation, and systemic markers","volume":"102","author":"Brown","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189733_bb0725","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1158\/0008-5472.CAN-12-1653","article-title":"Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer","volume":"72","author":"Giles","year":"2012","journal-title":"Cancer Res."},{"issue":"29","key":"10.1016\/j.bbcan.2026.189733_bb0730","article-title":"Detachment-induced FAK-STAT3-NNMT inhibits CTCs Anoikis to promote breast Cancer metastasis by enhancing fatty acid oxidation","volume":"13","author":"Tong","year":"2026","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0735","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13046-025-03568-4","article-title":"Inhibition of RACGAP1 sensitizes triple-negative breast cancer cells to ferroptosis by regulating CPT1A-dependent fatty acid metabolism","volume":"44","author":"Zhou","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0740","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.132","article-title":"Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer","volume":"7","author":"Qu","year":"2016","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0745","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nm.4055","article-title":"Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer","volume":"22","author":"Camarda","year":"2016","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0750","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s13402-025-01081-6","article-title":"Lipid metabolism in cancer stem cells: reprogramming, mechanisms, crosstalk, and therapeutic approaches","volume":"48","author":"Lee","year":"2025","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0755","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/mc.70072","article-title":"Doxorubicin resistance reprograms triple-negative breast Cancer cell metabolism via the fatty acid beta-oxidation (FAO)-CD36 regulatory circuit: relevance of enhanced FAO on tumor cell invasiveness","volume":"65","author":"Kumari","year":"2026","journal-title":"Mol. Carcinog."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0760","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189733_bb0765","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012162","article-title":"CPT1A inhibition alleviates plasmacytoid dendritic cell-mediated immune suppression in colon cancer through fatty acid oxidation modulation","volume":"13","author":"Wu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189733_bb0770","article-title":"Targeting lipid metabolism to overcome tamoxifen resistance in breast cancer: evaluating the synergistic therapeutic potential of quercetin","volume":"44","author":"Rifaat","year":"2025","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.bbcan.2026.189733_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.118216","article-title":"Metabolic reprogramming underlying the synergistic effect of energy metabolism inhibitors and chemotherapeutics in TNBC","volume":"252","author":"Zou","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189733_bb0780","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65150","article-title":"Resistance to different anthracycline chemotherapeutics elicits distinct and actionable primary metabolic dependencies in breast cancer","volume":"10","author":"McGuirk","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0785","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40659-019-0224-9","article-title":"Effects of glutamine deprivation on oxidative stress and cell survival in breast cell lines","volume":"52","author":"Gwangwa","year":"2019","journal-title":"Biol. Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0790","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/febs.16614","article-title":"Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer","volume":"290","author":"Li","year":"2023","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0795","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.gendis.2022.02.009","article-title":"Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)","volume":"9","author":"Hong","year":"2022","journal-title":"Genes Dis"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189733_bb0800","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.18632\/oncotarget.7406","article-title":"Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia","volume":"7","author":"Syu","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0805","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40170-023-00304-4","article-title":"Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer","volume":"11","author":"Reinema","year":"2023","journal-title":"Cancer Metab"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0810","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41556-022-00843-w","article-title":"Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance","volume":"24","author":"Romani","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb0815","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0820","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0825","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0830","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","article-title":"Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer","volume":"38","author":"Koppula","year":"2018","journal-title":"Cancer Commun."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189733_bb0835","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189733_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103864","article-title":"Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation","volume":"87","author":"Chaudhary","year":"2025","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb0845","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb0850","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189733_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124410","article-title":"Remodeling TME via feedback-driven photothermal-ferroptosis-immune cascade","volume":"335","author":"Wang","year":"2026","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0860","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/md24020075","article-title":"Anticancer effect of Pacificusoside D from the starfish Solaster pacificus in combination with 2-deoxy-D-glucose on oxidative phosphorylation in triple-negative breast Cancer cells MDA-MB-231","volume":"24","author":"Malyarenko","year":"2026","journal-title":"Mar. Drugs"},{"issue":"14","key":"10.1016\/j.bbcan.2026.189733_bb0865","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41388-023-02596-8","article-title":"Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment","volume":"42","author":"Baek","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189733_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218556","article-title":"Challenges in triple negative breast cancer treatment and therapeutic potential of the mitogen activated protein kinase pathway","volume":"653","author":"Nand","year":"2026","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189733_bb0875","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Sancho","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0880","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.50","article-title":"Hypoxia and metabolic adaptation of cancer cells","volume":"5","author":"Eales","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbcan.2026.189733_bb0885","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","article-title":"Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth","volume":"25","author":"Martinez-Outschoorn","year":"2014","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0890","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41420-026-03172-1","article-title":"Oncometabolite signatures from tumor-stroma crosstalk as potential non-invasive biomarkers","volume":"12","author":"Parascandolo","year":"2026","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0895","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of Cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0900","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1038\/s41467-026-74954-5","article-title":"Single cell spatial transcriptomics track the evolutionary hierarchy and microenvironment remodeling during breast carcinoma invasion","volume":"17","author":"Wang","year":"2026","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb0905","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","article-title":"The metabolism of cancer cells during metastasis","volume":"21","author":"Bergers","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189733_bb0910","article-title":"Metabolic reprogramming in the post-metastatic tumor microenvironment: multi-omics insights into determinants of immunotherapy response","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0915","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41588-025-02446-1","article-title":"p53 inactivation drives breast cancer metastasis to the brain through SCD1 upregulation and increased fatty acid metabolism","volume":"58","author":"Laue","year":"2026","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb0920","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1593\/neo.12858","article-title":"Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models","volume":"14","author":"Jiang","year":"2012","journal-title":"Neoplasia"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb0925","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/0008-5472.CAN-14-2258","article-title":"Spatially resolved metabolic phenotyping of breast cancer by desorption electrospray ionization mass spectrometry","volume":"75","author":"Guenther","year":"2015","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189733_bb0930","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.7150\/thno.45543","article-title":"Mass spectrometry imaging-based metabolomics to visualize the spatially resolved reprogramming of carnitine metabolism in breast cancer","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0935","article-title":"Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb0940","article-title":"Spatial transcriptomics in breast cancer reveals tumour microenvironment-driven drug responses and clonal therapeutic heterogeneity. NAR","volume":"6","author":"Jimenez-Santos","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2026.189733_bb0945","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.60","article-title":"Targeting cellular metabolism to improve cancer therapeutics","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0950","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13058-026-02336-2","article-title":"Targeting PFKFB3 to enhance CDK4\/6 inhibitor response in ER+ breast cancer","volume":"28","author":"Telang","year":"2026","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0955","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13046-025-03572-8","article-title":"Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer","volume":"44","author":"Varadkar","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb0960","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/metabo16010054","article-title":"Metabolic signatures of breast Cancer subtypes and the metabolic impact of chemotherapy","volume":"16","author":"Mattingly","year":"2026","journal-title":"Metabolites"},{"key":"10.1016\/j.bbcan.2026.189733_bb0965","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189733_bb0970","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of multidrug resistance 1","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0975","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: more than just drug efflux pumps","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189733_bb0980","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/mp200292c","article-title":"Drug resistance and cellular adaptation to tumor acidic pH microenvironment","volume":"8","author":"Wojtkowiak","year":"2011","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb0985","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J. Exp. Med."},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2026.189733_bb0990","article-title":"A review on the role of pyruvate kinase M2 in Cancer: from metabolic switch to transcriptional regulation","volume":"330","author":"Zulfareen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"34","key":"10.1016\/j.bbcan.2026.189733_bb0995","article-title":"MYC\/TET3-regulated TMEM65 activates OXPHOS-SERPINB3 pathway to promote progression and cisplatin resistance in triple-negative breast Cancer","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb1000","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1470-2045(00)00019-X","article-title":"Repopulation of tumour cells between cycles of chemotherapy: a neglected factor","volume":"1","author":"Davis","year":"2000","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb1005","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.7150\/thno.131708","article-title":"Tumor metabolic plasticity in therapy resistance: from the Warburg effect to mitochondrial hijacking","volume":"16","author":"Tzeng","year":"2026","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb1010","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.tibs.2026.04.008","article-title":"Emerging roles and regulatory mechanisms involved in glutamine metabolism","volume":"51","author":"Ryu","year":"2026","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2026.189733_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115464","article-title":"Glutamine metabolism in breast cancer and possible therapeutic targets","volume":"210","author":"Li","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb1020","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.celrep.2016.02.004","article-title":"Fatty acid oxidation-driven Src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast Cancer","volume":"14","author":"Park","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.celrep.2014.08.056","article-title":"Fatty acid uptake and lipid storage induced by HIF-1alpha contribute to cell growth and survival after hypoxia-reoxygenation","volume":"9","author":"Bensaad","year":"2014","journal-title":"Cell Rep."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189733_bb1030","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1021\/acs.jmedchem.3c00136","article-title":"Targeting the estrogen receptor for the treatment of breast Cancer: recent advances and challenges","volume":"66","author":"Rej","year":"2023","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189733_bb1035","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3390\/cells12242777","article-title":"FoxO3a drives the metabolic reprogramming in tamoxifen-resistant breast Cancer cells restoring tamoxifen sensitivity","volume":"12","author":"Fiorillo","year":"2023","journal-title":"Cells"},{"issue":"33","key":"10.1016\/j.bbcan.2026.189733_bb1040","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1200\/JCO.2010.34.4879","article-title":"Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer","volume":"29","author":"Miller","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189733_bb1045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.freeradbiomed.2019.09.004","article-title":"Mitochondrial fragmentation, elevated mitochondrial superoxide and respiratory supercomplexes disassembly is connected with the tamoxifen-resistant phenotype of breast cancer cells","volume":"143","author":"Tomkova","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2026.189733_bb1050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ctrv.2018.07.014","article-title":"Personalizing aromatase inhibitor therapy in patients with breast cancer","volume":"70","author":"Hamadeh","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2026.189733_bb1055","series-title":"ACSS2-Mediated Metabolic-Epigenetic Crosstalk Drives Fulvestrant Resistance and Represents a Novel Therapeutic Target","author":"Mogol","year":"2026"},{"key":"10.1016\/j.bbcan.2026.189733_bb1060","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"issue":"42","key":"10.1016\/j.bbcan.2026.189733_bb1065","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1038\/onc.2009.229","article-title":"Upregulation of lactate dehydrogenase a by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth","volume":"28","author":"Zhao","year":"2009","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb1070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrm3841","article-title":"The growing landscape of lysine acetylation links metabolism and cell signalling","volume":"15","author":"Choudhary","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189733_bb1075","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12156","article-title":"ERRalpha mediates metabolic adaptations driving lapatinib resistance in breast cancer","volume":"7","author":"Deblois","year":"2016","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb1080","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202502515RR","article-title":"Metabolic response to CDK4\/6 inhibition in ER+ breast Cancer creates a therapeutic vulnerability in drug-tolerant Persister cells","volume":"40","author":"Yang","year":"2026","journal-title":"FASEB J."},{"issue":"7658","key":"10.1016\/j.bbcan.2026.189733_bb1085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature22797","article-title":"The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival","volume":"546","author":"Wang","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189733_bb1090","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189733_bb1095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7368","key":"10.1016\/j.bbcan.2026.189733_bb1100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb1105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.bbcan.2026.189733_bb1110","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166628","article-title":"Zfp335 establishes eTreg lineage and neonatal immune tolerance by targeting Hadha-mediated fatty acid oxidation","volume":"133","author":"Wang","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"7755","key":"10.1016\/j.bbcan.2026.189733_bb1115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb1120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat. Med."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189733_bb1125","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/0008-5472.CAN-24-0030","article-title":"Natural killer cell regulation of breast Cancer stem cells mediates metastatic dormancy","volume":"84","author":"Bushnell","year":"2024","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189733_bb1130","doi-asserted-by":"crossref","first-page":"9125","DOI":"10.3390\/ijms21239125","article-title":"Cancer stem cell-associated pathways in the metabolic reprogramming of breast Cancer","volume":"21","author":"El-Sahli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb1135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41419-022-05111-1","article-title":"Lactate promotes metastasis of normoxic colorectal cancer stem cells through PGC-1alpha-mediated oxidative phosphorylation","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"38","key":"10.1016\/j.bbcan.2026.189733_bb1140","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.1073\/pnas.1106704108","article-title":"Metabolic state of glioma stem cells and nontumorigenic cells","volume":"108","author":"Vlashi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41420-026-03057-3","article-title":"AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma","volume":"12","author":"Berra","year":"2026","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189733_bb1150","doi-asserted-by":"crossref","DOI":"10.1002\/brv.70195","article-title":"Dynamic molecular networks unveil the mechanism behind hypoxia-induced tumour cell dormancy","author":"Wang","year":"2026","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.bbcan.2026.189733_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101125","article-title":"SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer","volume":"61","author":"Li","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189733_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103845","article-title":"Metastatic breast cancer cells are vulnerable to fatty acid oxidation inhibition through DDX3-DRP1-mediated mitochondrial plasticity","volume":"86","author":"Hsu","year":"2025","journal-title":"Redox Biol."},{"issue":"7664","key":"10.1016\/j.bbcan.2026.189733_bb1165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"issue":"7679","key":"10.1016\/j.bbcan.2026.189733_bb1170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41420-026-03231-7","article-title":"TFCP2L1 suppresses breast cancer progression by promoting ferroptosis through direct and PI3K\/AKT-mediated inhibition of GPX4","volume":"12","author":"Wang","year":"2026","journal-title":"Cell Death Discov."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189733_bb1180","doi-asserted-by":"crossref","first-page":"8757","DOI":"10.7150\/thno.116013","article-title":"Injectable SF-platform orchestrates GPX4-targeted ferroptosis-autophagy-immunogenic circuit for overcoming oxidative resistance in triple-negative breast cancer","volume":"15","author":"Yuan","year":"2025","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb1185","first-page":"3405","article-title":"SHMT2 promotes tumor growth through VEGF and MAPK signaling pathway in breast cancer","volume":"12","author":"Xie","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189733_bb1190","article-title":"Co-delivery of endoplasmic reticulum-targeted photosensitizer and Ido-1 inhibitor potentiates immunotherapeutic efficacy in triple-negative breast cancer","volume":"38","author":"Wang","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bbcan.2026.189733_bb1195","article-title":"IDO inhibition facilitates antitumor immunity of Vgamma9Vdelta2 T cells in triple-negative breast Cancer","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41419-026-08521-7","article-title":"Deubiquitinase UCH-L1 confers paclitaxel resistance via stabilizing PKM2 to promote glycolysis in triple-negative breast cancer","volume":"17","author":"Chen","year":"2026","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189733_bb1205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"47","key":"10.1016\/j.bbcan.2026.189733_bb1210","doi-asserted-by":"crossref","first-page":"43267","DOI":"10.1021\/jacs.5c18136","article-title":"Exploiting metabolic vulnerabilities in Cancer with a dual-transporter-targeted 2-Deoxyglucose analogue for low-dose, potent antitumor activity","volume":"147","author":"Jeon","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189733_bb1215","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/pros.21172","article-title":"Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies","volume":"70","author":"Stein","year":"2010","journal-title":"Prostate"},{"issue":"20","key":"10.1016\/j.bbcan.2026.189733_bb1220","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cmdc.201600276","article-title":"Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876","volume":"11","author":"Siebeneicher","year":"2016","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1225","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189733_bb1230","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1158\/0008-5472.CAN-16-2938","article-title":"Deletion of lactate dehydrogenase-a in myeloid cells triggers antitumor immunity","volume":"77","author":"Seth","year":"2017","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb1235","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1078-0432.CCR-13-2270","article-title":"Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer","volume":"20","author":"Polanski","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb1240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2026.168308","article-title":"Syrosingopine enhances immune checkpoint blockade efficacy by inhibition of MCTs and metabolic reprogramming in triple-negative breast cancer","volume":"1872","author":"Yang","year":"2026","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2026.189733_bb1245","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb1250","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189733_bb1255","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189733_bb1260","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.2022.6147","article-title":"Effect of metformin vs placebo on invasive disease-free survival in patients with breast Cancer: the MA.32 randomized clinical trial","volume":"327","author":"Goodwin","year":"2022","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189733_bb1265","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.7150\/thno.116250","article-title":"Metabolic targeting of oxidative phosphorylation enhances Chemosensitivity in triple-negative breast Cancer via a synergistic nanomedicine","volume":"15","author":"Shen","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2026.117629","article-title":"Complex I drives glutamine-dependent TCA cycle to support viability of MYC(high) breast cancer cells","volume":"45","author":"Anttila","year":"2026","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13058-025-02115-5","article-title":"Glutamine synthetase shields triple-negative breast cancer cells from ferroptosis in metastasis triggered by glutamine deprivation","volume":"27","author":"Yang","year":"2025","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189733_bb1285","first-page":"0858","article-title":"Delivery-graded programmable micelles achieve enhanced tumor starvation through combined glutamine deprivation and angiogenesis inhibition","volume":"5","author":"Wei","year":"2025","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.bbcan.2026.189733_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2026.179131","article-title":"Targeting lipid metabolism enzymes in breast Cancer: mechanistic basis and therapeutic vulnerabilities","volume":"1030","author":"Li","year":"2026","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189733_bb1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"4_Supplement","key":"10.1016\/j.bbcan.2026.189733_bb1300","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.SABCS25-PS5-01-16","article-title":"Abstract PS5\u201301-16: Phase II Trial of the FASN Inhibitor, Denifanstat (TVB-2640), Plus Trastuzumab in Combination with Paclitaxel or Endocrine Therapy (ET) in Patients with HER2+ Metastatic Breast Cancer (MBC) Resistant to Trastuzumab","volume":"32","author":"Haddad","year":"2026","journal-title":"Clinical Cancer Research"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189733_bb1305","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1310","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40164-026-00776-2","article-title":"Targeting the cancer metabolism-immunity interface: update and perspectives","volume":"15","author":"Di Carlo","year":"2026","journal-title":"Exp. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb1315","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.ymthe.2021.03.003","article-title":"Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers","volume":"29","author":"Yu","year":"2021","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1320","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-026-73467-5","article-title":"Glycosylated extracellular matrix drives immune suppression by modulating macrophage-T cell crosstalk in triple-negative breast cancer","volume":"17","author":"Tarantola","year":"2026","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1325","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-022-01236-0","article-title":"Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2026.189733_bb1330","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.2967\/jnumed.115.157875","article-title":"18F-FDG PET\/CT for monitoring of treatment response in breast cancer","volume":"57","author":"Avril","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13058-026-02225-8","article-title":"HSP90AA1-VDAC1 interaction contributes to breast cancer progression and doxorubicin resistance through PI3K\/AKT signaling","volume":"28","author":"Fang","year":"2026","journal-title":"Breast Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189733_bb1340","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjc.6600547","article-title":"Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death","volume":"87","author":"Aft","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1345","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12935-025-04006-3","article-title":"Adaptability of lung and liver metastatic breast cancer cells to glucose","volume":"25","author":"Layosa","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189733_bb1350","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1101\/gad.287235.116","article-title":"IKKbeta promotes metabolic adaptation to glutamine deprivation via phosphorylation and inhibition of PFKFB3","volume":"30","author":"Reid","year":"2016","journal-title":"Genes Dev."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189733_bb1355","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189733_bb1360","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41556-020-0477-0","article-title":"Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing","volume":"22","author":"Davis","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1365","first-page":"74","article-title":"Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial. NPJ","volume":"7","author":"Goodwin","year":"2021","journal-title":"Breast Cancer"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189733_bb1370","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/14728222.2023.2261631","article-title":"OXPHOS-targeting drugs in oncology: new perspectives","volume":"27","author":"Kalyanaraman","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189733_bb1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2026.189617","article-title":"Understanding tumor heterogeneity: implications for precision oncology and therapeutic strategies","volume":"1881","author":"Lv","year":"2026","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189733_bb1380","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s43556-025-00352-w","article-title":"Drug resistance in cancer: molecular mechanisms and emerging treatment strategies","volume":"6","author":"Li","year":"2025","journal-title":"Mol Biomed"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:08:41Z","timestamp":1791461321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":276,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304419X26002052"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189733","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming and plasticity in breast Cancer: Mechanisms driving tumor progression, metastasis, and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189733"}}